Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.10.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue:        
Consulting Revenue $ 14,425 $ 149,910
Cost of Consulting Services Provided 4,300 89,663
Gross Margin 10,125 60,247
Operating Expenses        
General and administrative 1,453,030 971,290 3,676,620 2,179,592
Research and development 538,031 545,644 1,449,065 1,009,987
Total Operating Expenses 1,991,061 1,516,934 5,125,685 3,189,579
Other Operating Income and (Loss)        
Other income from joint venture 187,031 587,374
Equity in loss from joint venture (1,773,445) (2,801,772)
Total Other Operating Income and (Loss) (1,586,414) (2,214,398)
Operating Loss (3,577,475) (1,506,809) (7,340,083) (3,129,332)
Other Income and (Expenses)        
Interest income 60,462 84,019
Financing costs (130,877) (982,436) (253,681)
Other income 23 47
Total Other Income and (Expenses) 60,462 (130,854) (898,417) (253,634)
Loss before income taxes (3,517,013) (1,637,663) (8,238,500) (3,382,966)
Income taxes
Net loss (3,517,013) (1,637,663) (8,238,500) (3,382,966)
Accumulated preferred stock dividend (119,000) (49,000) (214,667) (98,000)
Deemed additional dividend on preferred stock dividend due the beneficial conversion feature (49,373) (85,680)
Deemed dividend on issuance of Series B convertible preferred stock due to beneficial conversion feature (2,624,836)
Net loss attributable to common stockholders $ (3,685,386) $ (1,686,663) $ (11,163,683) $ (3,480,966)
Net Loss Per Common Share, Basic and Diluted $ (0.14) $ (0.17) $ (0.50) $ (0.37)
Weighted Average Number of Common Shares Outstanding 25,702,352 9,911,864 22,484,840 9,524,939